Cargando…
Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
Drug repositioning (i.e., drug repurposing) is the process of discovering new uses for marketed drugs. Historically, such discoveries were serendipitous. However, the rapid growth in electronic clinical data and text mining tools makes it feasible to systematically identify drugs with the potential...
Autores principales: | Su, Eric Wen, Sanger, Todd M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366063/ https://www.ncbi.nlm.nih.gov/pubmed/28348935 http://dx.doi.org/10.7717/peerj.3154 |
Ejemplares similares
-
Mining integrated semantic networks for drug repositioning opportunities
por: Mullen, Joseph, et al.
Publicado: (2016) -
Some data quality issues at ClinicalTrials.gov
por: Chaturvedi, Neha, et al.
Publicado: (2019) -
Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles
por: Tang, Eve, et al.
Publicado: (2015) -
Trends in clinical trials for stroke by cell therapy: data mining ClinicalTrials.gov and the ICTRP portal site
por: Negoro, Takaharu, et al.
Publicado: (2019) -
Obstacles to the reuse of study metadata in ClinicalTrials.gov
por: Miron, Laura, et al.
Publicado: (2020)